![]() That represents one additional death and six additional patients with vision loss since the last tally in March. Four of those patients have died and 14 have reported vision loss, according to the agency. Health officials said the outbreak is linked to using artificial tears. What are the risks?Īs of May 15, the CDC had identified 81 patients across 18 states who had been infected by Pseudomonas aeruginosa. On January 20, the CDC told doctors to avoid recommending the EzriCare product. In January, testing confirmed the Florida cases were caused by the same bacteria strain as cases in California, Connecticut and Utah. Over the course of the year, other states received multiple reports of drug-resistant Pseudomonas, including a report of a Washington man who died after suffering bloodstream infection linked to over-the-counter eye drops. The institution also determined the bacteria is resistant to many antibiotics. The hospital that reported the first infection determined it was caused by the Pseudomonas aeruginosa bacteria, which can cause infections in the blood, lungs or other parts of the body. Local health officials identified several more cases in subsequent months, with patients reporting eyes inflamed with heavy yellow pus that obscured most of the pupil. How were problems with eye drops first detected?Īccording to the Associated Press, a patient in Los Angeles County, California, who had seen an ophthalmologist in the spring of 2022 developed an eye infection. Pharmedica warned that patients who use the contaminated eye drops can risk going blind, but the company said it has not received any reports of infection or illness related to its product. Pharmedica "Purely Soothing, 15% MSM Drops." Pharmaceutical firm Pharmedica USA on March recalled two lots of "Purely Soothing, 15% MSM Drops," also over sterility concerns. The company said it initiated the recall "out of an abundance of caution" over concerns that cracks in some of the units' caps could compromise the drops' sterility and lead to infection.Īn Apotex spokesperson said the company has observed four bottles with cracked caps and that there have been no reports of negative health outcomes related to the product. Apotex "Brimonidine Tartrate Ophthalmic Solution, 0.15%." Another manufacturer, Apotex, on March 1 recalled six lots of its own brand of glaucoma drops, called "Brimonidine Tartrate Ophthalmic Solution, 0.15%," which is for patients with open-angle glaucoma or ocular hypertension.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |